Diagnostic criteria of NMOSD – The evolving spectrum

Key Points

• NMOSD diagnostic criteria are evolving, which may enhance early identification and treatment options.
• Key evidence includes updates on crucial biomarkers linked to disease mechanisms and progression.
• Analysis of the evolving spectrum suggests shifts in understanding of neuropathology and its connection with symptoms.
• These findings support the need for ongoing revisions to diagnostic approaches in autoimmune disorders.